Enhance Select 700

Our Take

Jabra saved its best OTC ideas for this one. Launched in 2025 to replace the Enhance Select 500 at the top of the lineup, the Select 700 is marketed as the world's smallest rechargeable receiver-in-ear hearing aid, and reviewers say its sound rivals premium prescription devices. The real headline, though, is the support: three years of remote audiologist care, a three-year warranty with loss and damage protection, and a 100-day trial are all included in the $1,695–$1,995 price. Add LE Audio with Auracast, hands-free calling on both iPhone and Android, and an IP68 rating, and it's the most complete OTC package on the market.

Everything here runs on a sealed rechargeable battery — 24-plus hours per charge, but no disposable-battery fallback if you're caught out with dead aids, and no telecoil for looped churches and theaters either. The charging case that carries your three spare charges runs bulkier than some competitors', too. Then there's the cost: at up to $1,995 per pair it's pricier than almost any other OTC option, and its speech-in-noise lab performance — a HearAdvisor SoundGrade B — is above average but underwhelming for the money. It's also a self-fit device for mild to moderate loss only; if your hearing loss goes beyond that, your hearing care professional can point you toward prescription options instead.

Who's it for? People who want the full package — top-tier hardware plus real human follow-up — without clinic visits. If you mainly want good sound and can skip the newest connectivity, the Enhance Select 300 at $1,695 list is the smarter value in the same lineup. But against prescription models like the Phonak Audéo Infinio, which starts at $2,498, the Select 700's bundle of care, warranty, and trial time holds up surprisingly well.